- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02419040
Treatment of Calcific Tendinitis of the Rotator Cuff
Treatment of Calcific Tendinitis of the Rotator Cuff - a Multi-centre, Randomized and Sham Controlled Trial (KALK Study)
Study Overview
Status
Intervention / Treatment
Detailed Description
Barbotage is a sonographically guided percutaneous needle aspiration and lavage of the calcium deposit in calcific tendinitis of the shoulder. Persisting pain in cacific tendinitis is considered to be a consequence of increased tendon volume or changed tendon texture in the area of the calcification which leads to secondary impingement and inflammation. Consequently, removal of the deposit should be a causal treatment measure.
Scientific evidence for the efficacy of the barbotage procedure in patients with persistent symptoms from calcific tendinitis is still limited. The cyclic often self-limiting course of the disease, and an anticipated placebo effect, questions about the method's efficacy can only be answered by high-quality randomized studies. In this trial the investigators want to randomize a cohort of patients to (1) Ultrasound guided needling, lavage and subacromial steroid injection, (2) Ultrasound guided subacromial steroid injection or (3) Ultrasound guided lidocain injection (sham). The investigators want to follow the patients over two years with repeated testing with a set of validated outcome measures together with radiologic re-examinations. The investigators want to find out whether the active treatments (1, 2) are more effective than the sham treatment and whether there are differences in outcome between the two active treatments. To increase the generalizability of the investigators' results, the investigators want to perform the study as a multi-centre study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sandvika, Norway, 1306
- Martina Hansen's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 30 years or older
- 3 months or more of shoulder pain
- Moderate to strong pain localized on the top and/or lateral side of the shoulder, exaggerated by activities above shoulder level
- Painful arc
- Positive Hawkin's test and/or Neer's sign for impingement
- Finding of one or more calcifications ≥5 mm in size on a standard anteriorposterior radiograph, localized proximally to the greater tubercle, together with a sonographic finding of one or more calcifications ≥5 mm in size on the short or long axis view, localized in the supraspinatus or infraspinatus tendon
- Morphological radiographic appearance of Molé type A, B or C12 (appendix 2) A: Dense, homogeneous with well-defined limits B: Dense, fragmented with well-defined limits C: Heterogeneous with poorly defined limits and sometimes with a punctuate appearance
- Ability to understand written and spoken Norwegian (Swedish/English)
- Existing signed informed consent and expected cooperation of the patients for the treatment and the follow-up
Exclusion criteria:
- Clinical and radiological signs of a recent spontaneous release of the deposit such as a sudden change in size or density of the deposit on ultrasound together with an acute onset of extreme shoulder pain
- Clinical signs of shoulder instability, glenohumeral arthritis, AC pathology, inflammatory arthropathy, fibromyalgia, frozen shoulder or cervical radiculopathy
- Sonographic signs for a rotator cuff tear (full thickness or partial thickness) and of a tear or a dislocation of the long head of the biceps tendon
- A history of surgical treatment of the relevant shoulder
- A subacromial injection with a corticosteroid during the last 3 months before inclusion
- Medical contraindications for any of the invasive procedures
- One of the following contraindications for the use of Lidocaine 10 mg/ml: Patients with serious hypovolaemia, known cardiac conduction disturbances, epilepsy or porphyrias, patients with known serious dysfunction of the liver or the kidneys.
- One of the following contraindications for the use of Triamcinolone 20 mg/ml: Patients with systemic infections unless specific anti-infective therapy is employed, patients with a local infection in the area of application, patients recently vaccinated with live vaccines, patients with known diabetes mellitus, renal or cardiac insufficiency, ulcerating colitis, gastric ulcer, psychosis, idiopathic thrombocytopenic purpura, or ocular herpes simplex.
- Concomitant medication with one of the following medicinal products: Anti-arrythmics such as mexiletine or class III antiarrythmics (e.g. amiodarone), muscle relaxants (e.g. suxamethonium) or antipsychotics (e.g. pimozide, sertindole, olanzapine, quetiapine, zotepine, tropisetrone, dolasetron), antibiotics such as quinopristin/dalfopristin.
- Any history of prior allergic/hypersensitivity reactions related to the study medication
- Knowledge of an ongoing pregnancy (Fertile women not using contraception and who are uncertain whether they are pregnant or not will have to perform a pregnancy test)
- Nursing women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Barbotage
Ultrasound guided needling, lavage and steroid/lidocain injection (20 mg Triamcinolon/9 ml Lidocain 1%) Ultrasound guided lidocain injection (10 ml Lidocain 1%, sham group) and home exercises
|
A 18-gauge needle connected to a 5 ml syringe with 4 ml of saline solution will be used to puncture the calcification with freehand technique and under constant sonographic monitoring.
With the tip of the needle placed in the center of the deposit, the calcification will be flushed.
Finally, a new 21-gauge needle will be introduced into the subacromial-subdeltoid bursa and 9 ml of 1% Lidocain hydrochlorid and 1 ml (20 mg) of Triamcinolon will be injected into the subacromial-subdeltoid bursa.
All patients will be instructed by a physioteherapist in home exercises.
Other Names:
|
Active Comparator: Corticosteroid injection
Ultrasound guided steroid/lidocain injection (20 mg Triamcinolon/9 ml Lidocain 1%) and home exercises
|
The tip of the 18-gauge needle will be placed in the soft parts outside of the rotator cuff and movements mimicking the lavage procedure will be performed.
A lavage procedure usually takes 5 minutes and the same period of time will have to be used for the mimicking maneuver.
Finally, a new 21-gauge needle will be introduced into the subacromial-subdeltoid bursa and 9 ml of 1% Lidocain hydrochlorid and 1 ml (20 mg) of Triamcinolon will be injected into the subacromial-subdeltoid bursa.
All patients will be instructed by a physioteherapist in home exercises.
Other Names:
|
Sham Comparator: Lidocain injection (sham)
Ultrasound guided lidocain injection (10 ml Lidocain 1%, sham group) and home exercises
|
The tip of the 18-gauge needle will be placed in the soft parts outside of the rotator cuff and movements mimicking the lavage procedure will be performed.
A lavage procedure usually takes 5 minutes and the same period of time will have to be used for the mimicking maneuver.
Finally, a new 21-gauge needle will be introduced into the subacromial-subdeltoid bursa and 10 ml of 1% Lidocain hydrochlorid will be injected into the subacromial-subdeltoid bursa.
All patients will be instructed by a physioteherapist in home exercises.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxford Shoulder Score
Time Frame: 4 months
|
Shoulder pain and disability
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxford Shoulder Score
Time Frame: after 2 and 6 weeks, and 8, 12 and 24 months
|
Shoulder pain and disability
|
after 2 and 6 weeks, and 8, 12 and 24 months
|
QuickDASH Disability of shoulder, arm and hand
Time Frame: after 2 and 6 weeks, and 4, 8, 12 and 24 months
|
Shoulder pain and disability
|
after 2 and 6 weeks, and 4, 8, 12 and 24 months
|
EQ 5D-5L
Time Frame: 4, 8, 12 and 24 months
|
Health related quality of life
|
4, 8, 12 and 24 months
|
Cross-over of patients
Time Frame: 4, 8, 12 and 24 months
|
number of patients crossing over to other group or other treatment
|
4, 8, 12 and 24 months
|
Adverse-events
Time Frame: 2 and 6 weeks, and 4 months
|
Patient reported adverse events
|
2 and 6 weeks, and 4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Size of calcific deposits
Time Frame: 4 and 24 months
|
Measured in millimeter AP radiographs
|
4 and 24 months
|
Volume of removed calcific deposit
Time Frame: Baseline
|
Volume of removed calcific deposit in milliliter
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stefan Moosmayer, MD, PhD, MHH Martine Hansens Hospital
Publications and helpful links
General Publications
- Moosmayer S, Ekeberg OM, Hallgren HB, Heier I, Kvalheim S, Blomquist J, Pripp AH, Juel NG, Kjellevold SH, Brox JI; KALK study group. KALK study: ultrasound guided needling and lavage (barbotage) with steroid injection versus sham barbotage with and without steroid injection - protocol for a randomized, double-blinded, controlled, multicenter study. BMC Musculoskelet Disord. 2017 Apr 4;18(1):138. doi: 10.1186/s12891-017-1501-9.
- Robinson DM, McInnis KC, Rhim HC, Tsitsilianos N. Lavage treatments for calcific rotator cuff tendinopathy. BMJ. 2023 Oct 11;383:p2248. doi: 10.1136/bmj.p2248. No abstract available.
- Moosmayer S, Ekeberg OM, Hallgren HB, Heier I, Kvalheim S, Juel NG, Blomquist J, Pripp AH, Brox JI. Ultrasound guided lavage with corticosteroid injection versus sham lavage with and without corticosteroid injection for calcific tendinopathy of shoulder: randomised double blinded multi-arm study. BMJ. 2023 Oct 11;383:e076447. doi: 10.1136/bmj-2023-076447.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Metabolic Diseases
- Pain
- Neurologic Manifestations
- Wounds and Injuries
- Joint Diseases
- Musculoskeletal Diseases
- Muscular Diseases
- Shoulder Injuries
- Tendon Injuries
- Arthralgia
- Calcium Metabolism Disorders
- Tendinopathy
- Shoulder Impingement Syndrome
- Shoulder Pain
- Calcinosis
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- KALK-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Impingement Syndrome
-
Mahidol UniversityCompletedSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Subacromial Pain Syndrome | Subacromial Impingement | Impingement Syndrome, ShoulderIndonesia
-
Copenhagen University Hospital, HvidovreUniversity of Copenhagen; Aalborg University; Metropolitan University CollegeCompletedSubacromial Impingement SyndromeDenmark
-
Uskudar State HospitalNot yet recruitingSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Shoulder Pain | Subacromial Impingement | Shoulder Impingement
-
Hadassah Medical OrganizationUnknownShoulder Impingement Syndrome.
-
King Saud UniversityUnknownImpingement Syndrome, ShoulderSaudi Arabia
-
National Taiwan University HospitalCompletedShoulder Impingement Syndrome (SIS); Round Shoulder Posture (RSP)Taiwan
-
Central Finland Hospital DistrictOulu University Hospital; Academy of FinlandActive, not recruitingSubacromial Impingement SyndromeFinland
-
Linkoeping UniversityCompletedSubacromial Impingement SyndromeSweden
-
Cairo UniversityCompletedImpingement Syndrome, ShoulderEgypt
-
Sevgi Medical CenterCompletedSubacromial Impingement Syndrome | Subacromial ImpingementTurkey
Clinical Trials on Barbotage
-
Martina Hansen's HospitalCompleted
-
Instituto de Investigación Sanitaria de la Fundación...RecruitingExtracorporeal Shockwave Therapy | Calcific Tendinopathy of Shoulders | Ultrasound Guided Barbotage TherapySpain
-
Medisch Spectrum TwenteUnknownCalcific TendinitisNetherlands
-
Istanbul University - Cerrahpasa (IUC)CompletedShoulder Pain | Calcific Tendinitis | Calcific Tendinitis of ShoulderTurkey
-
NYU Langone HealthTerminatedCalcific TendinitisUnited States